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Abstract
Background: The term ‘lower value services’ concerns healthcare that is of little or no value to the patient and
consequently should not be provided routinely, or not be provided at all. De-adoption of lower value care may
occur through explicit recommendations in clinical guidelines. The present study aimed to generate a comprehensive
list of lower value services for the Netherlands that assesses the type of care and associated medical conditions. The list
was compared with the NICE do-not-do list (United Kingdom). Finally, the feasibility of prioritizing the list was studied
to identify conditions where de-adoption is warranted.
Methods: Dutch clinical guidelines (published from 2010 to 2015) were searched for lower value services. The lower
value services identified were categorized by type of care (diagnostics, treatment with and without medication), type
of lower value service (not routinely provided or not provided at all), and ICD10 codes (international classification of
diseases). The list was prioritized per ICD10 code, based on the number of lower value services per ICD10 code,
prevalence, and burden of disease.
Results: A total of 1366 lower value services were found in the 193 Dutch guidelines included in our study. Of the
lower value services, 30% covered diagnostics, 29% related to surgical and medical treatment without drugs primarily,
and 39% related to drug treatment. The majority (77%) of all lower value services was on care that should not be
offered at all, whereas the other 23% recommended on care that should not be offered routinely. ICD10 chapters that
included most lower value services were neoplasms and diseases of the nervous system. Dutch guidelines appear to
contain more lower value services than UK guidelines. The prioritization processes revealed several conditions,
including back pain, chronic obstructive pulmonary disease, and ischemic heart diseases, where lower value
services most likely occur and de-adoption is warranted.
Conclusions: In this study, a comprehensive list of lower value services for Dutch hospital care was developed.
A feasible method for prioritizing lower value services was established. Identifying and prioritizing lower value
services is the first of several necessary steps in reducing them.
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Background
Quality of healthcare is reflected by “the degree to which
health services for individuals and populations increase
the likelihood of desired health outcomes and are consist-
ent with current professional knowledge” [1]. In accord-
ance with this definition, evidence-based medicine
means that good medical practices are replaced by better
ones when robust scientific evidence becomes available
and practices that are outdated or proven invaluable to
patients are de-adopted. This ideal world is in sharp
contrast with current medical practice [2, 3].
Current practice is not always high-value or evidence
based. Lower value or lower quality of care may either
be classified into misuse, overuse, or underuse of health-
care services [4]. The focus of this paper is overuse,
which occurs when a healthcare service is provided
under circumstances in which its potential for harm ex-
ceeds the possible benefit [4]. In our study we also in-
clude (cost-)ineffective care, inappropriate timing of
care, or care not in line with the patients’ wishes as
lower value services. Many questions remain about the
size of the problem. However, scientific literature sug-
gests that overuse represents between 10% and 30% of
provided services, of which a part is lower value care,
resulting in worse outcomes including death and un-
necessary costs [2, 3, 5]. We consider these services as
lower value services, because they have no net value for
the patient and de-adoption – a substantial reduction of
providing or using the service in daily medical practice –
is warranted.
During the last decade, efforts have been undertaken
to de-adopt lower value services. UK’s National Insti-
tute for Health and Care Excellence (NICE) started
working on de-adoption in 2005 [6], resulting in the
‘do-not-do list’ [7]. In the US, the National Physician
Alliance started developing ‘Top Five’ lists since 2009
and initiated the Choosing Wisely initiative in 2012 [8].
Australian activities were centered on the Medicare
Benefits Schedule [9]. The basis of these programs is
usually a (long) list of lower value services and some-
times a prioritization process to identify candidates for
de-adoption [9, 10].
The methods for creating these lists are diverse, and
prioritization based on impact proves to be difficult. For
example, Choosing Wisely lists varied widely in potential
impact on daily care and spending, and specialist soci-
eties tended to list colleague specialties’ services as lower
value [8]. UK research has shown additional challenges,
including a lack of reliable evidence on the clinical
merits of many services [11]. A prominent problem in
overuse is that interventions which are high-value for a
given subpopulation are inappropriately applied to other
populations [12]. Candidate lists tend to be large and the
potential gains in health and cost vary widely across
lower value services. Therefore, as resources for de-
adoption are limited, prioritization of lower value ser-
vices for de-adoption is warranted.
To conclude, there is need for an objective approach
to identify and prioritize lower value services for prac-
tical de-adoption [11]. This article describes the develop-
ment of a list of lower value services identified from 193
Dutch clinical practice guidelines, published between
2010 and 2015. The list was developed with the aim to
provide a comprehensive list of lower value services for
Dutch hospital care. Furthermore, our list was compared
with the NICE do-not-do list on several aspects, includ-
ing types of care and patient groups. Finally, the feasibil-
ity of prioritizing the list was studied. We hypothesized
the prevalence of a disease and disease burden (a ration-
ale for choice of criteria is given in the discussion) could
serve as robust criteria for prioritization.
Methods
Development of lower value services list
Dutch guidelines contain specific recommendations to
ensure that lower value care is not offered, or only ap-
plied to specific subpopulations or under limiting condi-
tions. In the current study we identified these do-not-do
recommendations. We have limited the analysis to the
most recent and up to date guidelines published between
January 2010 and May 2015 by the scientific societies, as
Dutch guidelines are recommended to be revised every
5 years [13]. The guidelines were taken from a guideline
database hosted by the Dutch Association of Medical
Specialists (www.kwaliteitskoepel.nl) covering (mental)
hospital care.
Firstly, we randomly selected 11 guidelines which were
fully read by four researchers (SD, EV, JW and MEAM)
to identify recommendations on care that should not be
offered and care that should not be offered routinely.
For each do-not-do recommendation identified, we
listed whether the key term identifying the do-not-do
recommendation was one of the search terms applied by
NICE in the ‘do-not-do’ study (for example, ‘discontin-
ued’, ‘should not’, ‘do not’ [14]) or a new term that should
be added (e.g., ‘omit’). Recommendations that focused on
too little use of care (underuse) were not included. For
example: “Restraint is not necessary when starting opi-
oids and will lead to a substantial deterioration in quality
of life by the experienced severe shortness of breath”
(Guideline: Palliative care for people with chronic ob-
structive pulmonary disease). Finally, recommendations
that focus on organization of care were not included.
For example, “It is not recommended that professionals
who have no experience with patients/offenders with
antisocial personality (disorder) address the issue of the
committed violence” (Guideline: Domestic violence in
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children and adults). A fifth researcher (RBK) was con-
sulted in case of no consensus.
Furthermore, the specific section of the guideline in
which the do-not-do recommendation was written was
identified. The standard format of guidelines contains
five sections: clinical question, recommendations, sub-
stantiation, considerations, and justification. As in the
first five guidelines, all the recommendations were found
in the sections ‘recommendations’ and ‘considerations’ of
the guidelines; subsequently, only these sections of the
electronic/PDF copy of a guideline were searched with
the terms from Table 1.
Another nine guidelines were independently screened
by the four researches (SD, MEAM, EV and JW) to de-
termine the inter-rater reliability. Inter-rater reliability
was analyzed by calculating Fleiss’ Kappa (k) for multiple
raters [15].
Using this method, the other guidelines were screened
(in total 193), and any ambiguities were discussed with
another researcher until consensus was reached. When
guidelines were not constructed according to the stand-
ard format and therefore did not contain the paragraphs
with recommendations and considerations, they were
fully screened. For each do-not-do recommendation
identified we assessed whether the care should not be of-
fered at all or should not be offered routinely to all pa-
tients and what type of care the recommendation was
about: diagnosis, treatment without medication, treat-
ment with medication, and a residual category.
Guidelines that have been published in English were
screened with English terms. Patient versions of guide-
lines were not included and also addenda to guidelines
with original publication date before 2010 were
excluded.
Connection with International Classification of Disease,
Tenth Edition (ICD10) code
The lower value services described in the do-not-do rec-
ommendations were provided with an ICD10 code by
searching within the ICD10 encoding [16] on the condi-
tion in question. When necessary, additional information
was sought in the guideline from which the lower value
service originated and/or Wikipedia. If the lower value
service was related to two (or more) conditions, the
guideline topic was selected for the ICD10 coding. For
example, the guidance “European Guidelines on cardio-
vascular disease prevention in clinical practice” included
the recommendation “Beta-blockers and thiazide di-
uretics are not recommended in hypertensive patients
with multiple metabolic risk factors increasing the risk
of new-onset diabetes”. This recommendation was cate-
gorized to the ICD10 code for hypertensive diseases. If
the patient population receiving the lower value service
could not be related to an ICD10 code, for example, in
the case of prevention in a healthy population, then the
ICD10 code of the disease prevented was chosen. For
example, the lower value service “Do not use throat
swabs when investigating for possible meningococcal
disease” concerns the population with suspected menin-
gococcal disease. Since there is no ICD10 code for this
population, the ICD10 code of meningococcal disease
was chosen. Complex cases were discussed between two
researchers until consensus was reached. ICD10 codes
were then aggregated to ICD10 chapters, the highest
level of categorization in ICD10.
Comparison with NICE do-not-do database
In the development of NICE guidelines, clinical practices
were identified which should not be used at all or should
not be used routinely. These practices have been col-
lected in the do-not-do database [7]. NICE made an
Excel file of the database (dated September 29, 2015)
available to us upon request. We compared the average
number of do-not-do recommendations per NICE
guideline with the Dutch number. Furthermore, for each
recommendation from the NICE do-not-do database we
assessed whether the care should not be offered at all or
should not be offered routinely and what type of care was
concerned (diagnosis, treatment without medication,
treatment with medication). Finally, the same procedure
with respect to assigning ICD10 codes was followed.
Prioritization
Prioritization of conditions for further research on lower
value services for de-adoption was done by aggregating the
lower value services described in the do-not-do recom-
mendations by ICD10 codes, as the data for prioritization
were only available at this level of aggregation and not for
individual lower value services. Per ICD10 code we
Table 1 Shortlist search terms
Dutch [English translation] English
Niet [Not] Discontinue/discontinuation
Geen [No] Not
Stop [Stop] No
Onvoldoende [Insufficient] Ineffective
Zelden [Seldom] Uncertain
Alleen [Only] Avoid
Kosten [Cost] Rarely
Vermijd/Vermeden [Avoid] Stop
Achterwege [Omit]
Onnodig [Unnecessary]
Afgeraden [Discourage]
Ontraden [Dissuade]
Staken/Gestaakt [Cease]
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identified prevalence estimates and disease burden as
available in the Global Burden of Disease studies [17]
(a detailed description of the methodology is given in
Additional file 1: Appendix 1). Prioritization was based
on the number of lower value services per ICD10 code,
prevalence and burden of disease (expressed in Years
Lived with Disabilities (YLD) and Disability Adjusted
Life-Years (DALY)). Each criterion was categorized in
four groups according to level. Per criterion, the group
with the highest levels was assigned four points. Subse-
quently, the ICD10 codes were prioritized by the sum of
scores for the number of lower value services, prevalence,
YLD, and DALY (Method 1), with the highest score (up to
16) indicating the highest priority for de-adoption. As we
were interested in the impact of burden of disease mea-
sures on prioritization (both YLD and DALY reflect
burden of disease) we omitted these criteria in sensitivity
analyses, and the prioritization was repeated for the sum
of the number of lower value services and prevalence
(Method 2; maximum score 8). For the NICE do-not-do
database the same prioritization was performed, using
UK-specific data on prevalence, YLD and DALY. In
Additional file 1: Appendix 1, a full description of the
prioritization methodology is given.
Results
Descriptive Dutch list of lower value services
In total, 1366 lower value services were extracted from
the 193 Dutch guidelines on (mental) hospital care, im-
plying that each guideline contained, on average, 7.1
(modus = 0; median = 5; maximum = 45) lower value ser-
vices. Of these guidelines, 29 did not contain any lower
value services. The inter-rater reliability was 0.803 (Fleiss
k), indicating a substantial agreement [18]. Table 2
shows the average number of lower value services per
guideline between 2010 and 2015. The number of guide-
lines published in 2014 and 2015 was relatively low be-
cause of the ending of a subsidy program. The majority
of lower value services was, if necessary after deliber-
ation within the project group, successfully linked to an
ICD10 code. In 98 cases (<8%), no ICD10 code could be
assigned, predominantly because the recommendation
was ambiguous concerning the patient group, or the pa-
tient group was insufficiently specific (e.g., ‘essentially,
laparoscopic surgery does not require different fluid
management than open surgery’).
Of the lower value services, 415 (30%) related to diag-
nostics, such as ‘There is no place for FDG-PET in the
detection of micro metastases’ (guideline anus carcin-
oma, Dutch list); 399 lower value services (29%) related
to non-drug treatment, such as ‘The insertion of a
pulmonary artery catheter (PAC) in case of acute heart
failure is rarely needed’ (guideline heart failure, both in
Dutch list and NICE database). Finally, 527 lower value
services (39%) related to drug treatment, such as
‘Methotrexate is not recommended for hidradenitis sup-
purativa’ (guideline acneiform dermatoses, Dutch list).
The remaining 25 (2%) lower value services did not fit
into these categories (e.g., vaccination or recommenda-
tions on referral and discharge procedures). The major-
ity (77%) of all lower value services concerned care that
should not be offered at all, whereas the other 23% rec-
ommended on care that should not be offered routinely.
Figure 1 shows the number of lower value services
identified per ICD10 chapter. For the Dutch guidelines,
‘neoplasms’ and ‘diseases of the nervous system’ are the
most frequent chapters, followed by ‘symptoms, signs
and abnormal clinical and laboratory findings – not else-
where classified’, ‘diseases of the circulatory system’, ‘dis-
eases of the musculoskeletal system and connective
tissue’, and ‘mental and behavioral disorders’. Relatively
few lower value services were found in ICD10 chapters
‘external causes of morbidity and mortality’, ‘conditions
originating in the perinatal period’, and ‘diseases of the
blood and blood-forming organs and certain disorders
involving the immune mechanism’.
Comparison with NICE do-not-do recommendations
The database contained 188 guidelines in which 1006
do-not-do recommendations (lower value services)
were found. The UK guidelines thus covered relatively
few lower value services, on average, 5.4 (modus = 1;
median = 3; maximum = 32) per guideline. UK guide-
lines covered slightly fewer lower value services related
to diagnostics (28%) and non-drug treatment (25%),
and relatively many lower value services related to drug
treatment (46%). In addition, UK lower value services
less likely described care that should not be offered at
all (68%), whereas the other 32% recommended care
that should not be offered routinely. Finally, UK do-
not-do recommendations more frequently covered
mental and behavioral disorders, diseases of the genito-
urinary system, pregnancy, childbirth, and the puerper-
ium (Fig. 1).
Table 2 Number of lower value services per year in Dutch
guidelines
Year Number of
guidelines
published
Number of lower
value services
Average number of
lower value services
per guideline
2010 61 357 5.85
2011 41 249 6.07
2012 44 347 7.89
2013 35 312 8.91
2014 2 45 22.5
2015 6 59 9.83
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Prioritization of Dutch lower value services
As mentioned, the ranking was performed according to
two different strategies. The results of the ranking by
prevalence, DALY, YLD and number of recommenda-
tions (method 1) is represented in Fig. 2. Both dorsalgia
(back pain) and other chronic obstructive pulmonary
diseases were assigned the maximum score of 16,
followed by other acute ischemic heart diseases, iron de-
ficiency anemia, lichen planus, and other disorders of
bone (in particular the complex regional pain syndrome
type 1), each of which scored 14 points. Furthermore,
out of the top-25 prioritized ICD10 codes, 10 (40%) are
in chapter M, i.e., diseases of the musculoskeletal system
and connective tissue. When the ranking was performed
by only prevalence and number of recommendations
(method 2, Fig. 3), three diseases obtained the maximum
score, i.e., dorsalgia, other chronic obstructive pulmon-
ary disease, and lichen planus.
Generally speaking, neoplasm ICD10 codes receive a
more modest priority when number of recommendations
and prevalence are the only criteria for prioritization, but
receive higher priority when burden of disease criteria are
included. Ranking results for UK lower value services are
provided in Additional file 1: Appendix 2.
Discussion
In this study, we developed a comprehensive list of
lower value services for Dutch hospital care and studied
the feasibility of prioritizing the list. In addition, we re-
peated the descriptive analyses and prioritization for the
UK do-not-do database. In total, 1366 lower value ser-
vices were extracted from 193 Dutch guidelines. Of the
lower value services 30% covered diagnostics, 29% re-
lated to non-drug treatment, and 39% to drug treatment.
The majority (77%) of all lower value services was on care
that should not be offered at all, whereas the other 23%
recommended on care that should not be offered rou-
tinely. ICD10 chapters that included most lower value ser-
vices were neoplasms and diseases of the nervous system.
Further research and policy aimed at reducing lower value
services are highly warranted. A recent Dutch study
showed avoidable costs are evident in healthcare: about 60
million euro can be saved in the Netherlands, when 23
lower value surgical procedures – actual use approxi-
mately 11,800 in the Netherlands – are no longer per-
formed [19].
The prioritization processes revealed several ICD10
codes with relatively high prevalence and disease burden
where lower value services most likely occur and de-
Fig. 1 Number of lower-value services per ICD10 group for Dutch guidelines and NICE do-not-do list
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adoption is warranted, including back pain, chronic
obstructive pulmonary diseases, acute ischemic heart
diseases, iron deficiency anemia, lichen planus, disorders
of bone, and malignant neoplasms of bronchus and lung.
These findings are relevant, given the corresponding
opportunities for further research. However, this
prioritization should be interpreted with caution, it does
not prove lower value services are actually provided to
these groups. Rather, based on robust criteria, we rec-
ommend further research into the presence of lower-
value services in these conditions.
The Dutch and UK list show similarities as well as dif-
ferences. Dutch guidelines appear to contain more lower
value services than the UK guidelines (7.1 on average vs.
5.4, respectively). These data suggest Dutch guideline de-
velopers might be more aware of the existence of lower
value services or might consider incorporating do-not-do
recommendations in guidelines more important than their
UK colleagues. However, differences in followed method-
ology might have spurred this difference. We only in-
cluded guidelines published between 2010 and 2015,
whereas NICE started in 2005, and we have shown an in-
crease in number of do-not-do recommendations per
year. Moreover, we also included recommendations from
consideration sections. This probably makes the Dutch list
more comprehensive.
The development of a comprehensive list of lower
value services and prioritization is only the first of
several necessary steps in actually reducing lower value
services, starting with measuring the actual use of lower
value services. As discussed above, many uncertainties
remain about the prevalence of lower value services. Es-
timates for the Netherlands date back to the ‘90s [3], or
have to be gauged from case studies. Like Morgan et al.
[5], we support routine monitoring of potential “out-
breaks” in use of diagnostics and treatment methods and
variation in routine care. Such an approach entails large
scale measurements using real time administrative data
with sufficient clinical detail to assess appropriateness of
care and risk adjustment, which are not yet available in
the Netherlands. De Vries et al. [20] recently identified
115 lower value care measures, which mainly focused on
the cure sector. Apart from these indicators, our data-
base could be used for developing new and valid indica-
tors for lower value care.
Early evidence shows that dissemination of recommen-
dations alone is not sufficient to ensure de-adoption, and
that additional specific interventions are required. For
Fig. 2 Ranking results from Dutch guidelines (method 1)
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example, a first evaluation of the Choosing Wisely initia-
tive showed marginal reductions of use, if any [21],
whereas Schwartz et al. [22] showed that alternative pay-
ment models with global budgets successfully discouraged
overuse. Several papers discuss interventions or pro-
vide roadmaps for reducing overuse or promoting/ad-
vancing de-adoption [5, 23, 24]. Most notably, Niven
et al. [24] proposed a conceptual model for the
process of de-adoption; which shares much of the ori-
ginal Knowledge-to-Action Cycle [25]. The proposed
framework emphasizes in-depth analyses of barriers
and facilitators, which is deeply grounded in adjacent
fields such as implementation science [26]. Paprica et al.
[27] underlined that stakeholders should be involved in
de-adoption. In their analysis, they point to the trinity by
Lomas et al. [28] – medical effectiveness research (con-
text-free scientific evidence), social science-oriented re-
search (context-sensitive scientific evidence), and the
expertise, views, values, and realities of stakeholders (col-
loquial evidence) – and show that colloquial evidence has
a major influence in de-adoption. Local stakeholder in-
volvement is therefore pivotal in de-adoption initiatives.
In this study, we focused on identifying and prioritizing
lower value services. This process is central to the Niven
framework and is ideally performed concomitant with
stakeholder engagement. Stakeholders could, for example,
participate in choosing and weighting prioritization criteria.
In addition, expert panels could be employed to further
rank our list of lower value services on appropriateness of
the services and priority for de-adoption [29].
In the Netherlands, the exact above formula for
reducing lower value care is being followed. The Dutch
Federation of University Medical Centers recently initi-
ated a 4-year program for reducing lower value services.
The current study is the first outcome of this project
and, in June 2016, all eight university hospitals com-
menced local de-adoption pilot projects. The current list
and prioritization contributed to selecting appropriate
conditions and lower value services for de-adoption. The
list will be integrated with the guideline database
(www.richtlijnendatabase.nl) of the Dutch Association of
Medical Specialists. On this website, all lower value ser-
vice recommendations will be highlighted, and special
attention will be paid to the fact that, in these cases, not
acting is a better solution.
Limitations
The methodology we developed for this study has a num-
ber of limitations, for a large part related to ambiguity in
guideline recommendations and lacking data. Ambiguity
in guideline recommendations sometimes made it difficult
to discern lower value services, or to distinguish between
Fig. 3 Ranking results from Dutch guidelines (method 2)
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care that should not be offered at all, and care that should
not be offered routinely. In some cases, it was explicitly
mentioned that care was not recommended, whereas, in
others, this was less explicit. For example, “No recommen-
dations can be given for the use of tramadol or oxycodone
in the emergency medical treatment on the basis of the
emergency care literature” (Guideline: Pain management
in emergency care chain). These recommendations have
been included as the context shows that application is not
indicated. To cope with ambiguous recommendations,
regular meetings were held to discuss disputable items
until consensus was reached. Nevertheless, ambiguity of
guideline recommendations or ambiguous populations
may have biased our findings.
The Dutch list of lower value services was developed
to comprehensively cover lower value services in Dutch
hospital care. We restricted inclusion of guidelines to
the period from 2010 until May 2015, as Dutch guide-
lines are recommended to be revised every 5 years [13].
As a result, we could not take into account important
conditions or diseases covered by older guidelines, by
guidelines published after May 2015 or not covered by
guidelines at all. Furthermore, we might have missed
some lower value services that lacked one of the key-
words we identified. We therefore recommend to rou-
tinely update the list and to update the list of keywords.
Ideally, lower value services are prioritized based on
the following criteria: the availability of evidence that a
service is ineffective or harmful, patient safety, potential
health and cost impact of de-adoption, availability of al-
ternative practices [30], and the actual use of the lower
value service. Clarifying such information for over 1000
lower value services proved impossible and much of
such detailed information is currently lacking. We there-
fore developed alternative criteria as close as possible to
the criteria proposed by Elshaug et al. [30]. Notwith-
standing the methodological hurdles and data problems,
we consider the prioritization results robust for singling
out new and valid information besides the list itself, and
both are useful for informing de-adoption programs.
Finally, in this study, stakeholders were not involved,
which should be a next step in the process of de-
adoption. The prioritization results may be important in-
put for this consultation step.
Conclusions
In this study, a comprehensive list of lower value services
for Dutch hospital care was developed. The majority of
lower value services covered care that should not be of-
fered at all; 30% of lower value services covered diagnos-
tics, 29% were related to non-drug treatment, and 39% to
drug treatment. Comparing the list with its UK counter-
part revealed that Dutch guidelines appear to contain
more lower value services than the UK guidelines. Finally,
a feasible method for prioritizing lower value services was
established. The development of a comprehensive list of
lower value services and prioritization is only the first of
several necessary steps in reducing lower value services.
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Additional file 1: Prioritization methodology and UK results are
presented in appendix 1 and 2. (DOCX 230 kb)
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